Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.

The Canadian journal of cardiology - 1 Nov 2021

Vikulova Diana N, Trinder Mark, Mancini G B John, Pimstone Simon N, Brunham Liam R

Abstract excerpt

BACKGROUND: Familial hypercholesterolemia (FH), familial combined hyperlipidemia (FCHL), and elevated lipoprotein (a) (Lp[a]) increase risk of premature coronary artery disease (CAD). The objective of this study was to assess the prevalence of FH, FCHL, elevated Lp(a) and their impact on management in patients with premature CAD. METHODS: We prospectively recruited men ≤ 50 years and women ≤ 55 with obstructive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to British Columbia
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Angiography

Share to Coronary Artery Disease

Share to Follow-Up Studies

Share to Hyperlipidemia, Familial Combined

Share to Hyperlipoproteinemia Type II

Share to Lipoprotein(a)

Source

Identifiers

PMID: 34455025
DOI: 10.1016/j.cjca.2021.08.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.PMID 34455025Read ↗

Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.Semantic proximity Read ↗

Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.Semantic proximity Read ↗

Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors.Semantic proximity Read ↗

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.Semantic proximity Read ↗

Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.Semantic proximity Read ↗

Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).Semantic proximity Read ↗

Familial lipoprotein disorders in patients with premature coronary artery disease.Semantic proximity Read ↗

Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).Semantic proximity Read ↗

Familial hypoalphalipoproteinemia in premature coronary artery disease.Semantic proximity Read ↗

Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis.Semantic proximity Read ↗

Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice.Semantic proximity Read ↗

Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.